GlassScriptPhysician profile
Taryn Steinbeck
NPI 1144972019
$1,449.87
in general payments reported to CMS, 2019-2025
18 companies · $443 in 2025
The $443 reported for 2025 was more than what 84% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $579 · 2023: $108 · 2024: $320 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.05 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $74.48 | 2022 | |
| Medtronic, INC. | $58.17 | 2022-2023 | Intellis Adaptivestim, Venaseal |
| Novo Nordisk INC | $45.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.89 | 2022 | |
| Supernus Pharmaceuticals, INC. | $43.10 | 2022 | |
| Amgen INC. | $42.62 | 2022-2023 | Otezla, Repatha |
| Antares Pharma, INC. | $41.66 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.89 | 2022 | |
| Lilly USA, LLC | $33.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.73 | 2022 | |
| Axsome Therapeutics, INC. | $24.29 | 2022 | |
| Arbor Pharmaceuticals, INC. | $18.99 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.87 | 2022 | |
| Glaxosmithkline, LLC. | $15.74 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taryn Steinbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.